​

Pediatrix Medical Group (MD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MD Stock Forecast

Pediatrix Medical Group (MD) stock forecast, based on 28 Wall Street analysts, predicts a 12-month average price target of $18.17, with a high of $27.00 and a low of $8.00. This represents a 41.73% increase from the last price of $12.82.

$5 $10 $15 $20 $25 $30 High: $27 Avg: $18.17 Low: $8 Last Closed Price: $12.82

MD Stock Rating

Pediatrix Medical Group stock's rating consensus is Hold, based on 28 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (46.43%), 15 Hold (53.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 28 0 15 13 Strong Sell Sell Hold Buy Strong Buy

MD Price Target Upside V Benchmarks

TypeNameUpside
StockPediatrix Medical Group41.73%
SectorHealthcare Stocks 35.94%
IndustryMedical Care Facilities Stocks24.63%

Price Target Trends

1M3M12M
# Anlaysts--4
Avg Price Target--$11.25
Last Closing Price$12.82$12.82$12.82
Upside/Downside---12.25%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25-35--8
Mar, 25-35--8
Feb, 25-35--8
Jan, 25-35--8
Dec, 24-35--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 07, 2024David MacDonaldTruist Financial$13.00$12.137.17%1.40%
Sep 26, 2024Jack SlevinJefferies$14.00$11.2624.33%9.20%
Aug 15, 2024David MacDonaldTruist Financial$10.00$10.16-1.57%-22.00%
Jun 07, 2024Pito ChickeringDeutsche Bank$8.00$6.8916.11%-37.60%
Dec 05, 2022Credit Suisse$27.00$16.2865.85%110.61%
Aug 11, 2022Credit Suisse$28.00$21.2731.64%118.41%
May 03, 2022Credit Suisse$30.00$19.0257.73%134.01%
May 02, 2022Mizuho Securities$23.00$19.3019.17%79.41%
Apr 27, 2022Leerink Partners$24.00$22.735.59%87.21%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 26, 2024JefferiesBuyupgrade
Aug 15, 2024UBSHoldHoldhold
Jun 07, 2024Deutsche BankHoldupgrade
May 15, 2024Truist FinancialHoldHoldhold
Dec 05, 2022Credit SuisseOutperformOutperformhold
Aug 11, 2022Credit SuisseOutperformOutperformhold
Apr 27, 2022SVB LeerinkMarket PerformMarket Performhold
Feb 23, 2022Credit SuisseOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-0.11$1.54$0.79$-0.72$-1.24---
Avg Forecast$1.23$1.53$1.69$1.25$1.35$1.53$1.61$1.39
High Forecast$1.29$1.61$1.80$1.31$1.40$1.69$1.75$1.51
Low Forecast$1.15$1.44$1.63$1.13$1.27$1.34$1.53$1.32
Surprise %-108.94%0.65%-53.25%-157.60%-191.85%---

Revenue Forecast

$2B $2B $2B $2B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.73B$1.91B$1.97B$1.99B$2.01B---
Avg Forecast$2.08B$1.90B$1.96B$2.02B$2.00B$1.94B$2.00B$2.08B
High Forecast$2.16B$1.97B$2.06B$2.03B$2.02B$2.06B$2.00B$2.22B
Low Forecast$1.98B$1.81B$1.90B$1.95B$1.97B$1.86B$2.00B$2.00B
Surprise %-16.47%0.77%0.61%-1.33%0.81%---

Net Income Forecast

$-2B $-1B $-700M $-300M $100M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-9.58M$130.96M$66.33M$-60.41M$-103.61M---
Avg Forecast$-1.09B$107.65M$82.66M$-60.41M$109.72M$115.03M$135.06M$116.64M
High Forecast$-874.54M$129.18M$105.79M$-42.62M$115.06M$139.31M$144.05M$124.41M
Low Forecast$-1.31B$86.12M$59.54M$-78.20M$104.38M$110.25M$126.06M$108.87M
Surprise %-99.12%21.66%-19.75%--194.43%---

MD Forecast FAQ

Is Pediatrix Medical Group stock a buy?

Pediatrix Medical Group stock has a consensus rating of Hold, based on 28 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 15 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Pediatrix Medical Group is a neutral investment for most analysts.

What is Pediatrix Medical Group's price target?

Pediatrix Medical Group's price target, set by 28 Wall Street analysts, averages $18.17 over the next 12 months. The price target range spans from $8 at the low end to $27 at the high end, suggesting a potential 41.73% change from the previous closing price of $12.82.

How does Pediatrix Medical Group stock forecast compare to its benchmarks?

Pediatrix Medical Group's stock forecast shows a 41.73% upside, outperforming the average forecast for the healthcare stocks sector (35.94%) and outperforming the medical care facilities stocks industry (24.63%).

What is the breakdown of analyst ratings for Pediatrix Medical Group over the past three months?

  • April 2025: 0% Strong Buy, 37.50% Buy, 62.50% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 37.50% Buy, 62.50% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 0% Strong Buy, 37.50% Buy, 62.50% Hold, 0% Sell, 0% Strong Sell.

What is Pediatrix Medical Group’s EPS forecast?

Pediatrix Medical Group's average annual EPS forecast for its fiscal year ending in December 2025 is $1.53, marking a -223.39% decrease from the reported $-1.24 in 2024. Estimates for the following years are $1.61 in 2026, and $1.39 in 2027.

What is Pediatrix Medical Group’s revenue forecast?

Pediatrix Medical Group's average annual revenue forecast for its fiscal year ending in December 2025 is $1.94B, reflecting a -3.44% decrease from the reported $2.01B in 2024. The forecast for 2026 is $2B, and $2.08B for 2027.

What is Pediatrix Medical Group’s net income forecast?

Pediatrix Medical Group's net income forecast for the fiscal year ending in December 2025 stands at $115.03M, representing a -211.02% decrease from the reported $-104M in 2024. Projections indicate $135.06M in 2026, and $116.64M in 2027.